Triamcinolone Acetonide Prevents Enhancement of Hypoxia-induced Neuronal and Inducible Nitric Oxide Synthases in the Retinas of Rats with Oxygen-induced Retinopathy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: We investigated whether oxygen-induced retinopathy (OIR) results in changes in the protein expression of neuronal and inducible nitric oxide synthases (nNOS and iNOS, respectively) in rat model of OIR. In addition, we evaluated whether treatment of rats with triamcinolone acetonide (TA) prevents this response. Methods: To promote OIR, Sprague-Dawley rats were exposed to hyperoxia from postnatal day 2 (P2) to P14. They were then returned to normoxia after P15. TA was injected into the right vitreous of P15 rats, while saline was injected into the left vitreous. At P18 the expression of nNOS and iNOS was determined using Western blotting and immunostaining techniques in retinas obtained from control rats. Results: In P18 OIR rats, the abundance of nNOS and iNOS protein was significantly increased compared with controls. These increases were not observed in the retinas of rats treated with TA. The change in expression of nNOS and iNOS were specific to parvalbumin and glial fibrillary acidic protein-positive cells. Treatment with TA prevented the increased expression of nNOS and iNOS in all samples. Conclusions: Hypoxia upregulates expression of nNOS and iNOS in OIR rat retinas, which is can be prevented by treatment with TA.
Abstract
Purpose: We investigated whether oxygen-induced retinopathy (OIR) results in changes in the protein expression of neuronal and inducible nitric oxide synthases (nNOS and iNOS, respectively) in rat model of OIR. In addition, we evaluated whether treatment of rats with triamcinolone acetonide (TA) prevents this response. Methods: To promote OIR, Sprague-Dawley rats were exposed to hyperoxia from postnatal day 2 (P2) to P14. They were then returned to normoxia after P15. TA was injected into the right vitreous of P15 rats, while saline was injected into the left vitreous. At P18 the expression of nNOS and iNOS was determined using Western blotting and immunostaining techniques in retinas obtained from control rats. Results: In P18 OIR rats, the abundance of nNOS and iNOS protein was significantly increased compared with controls. These increases were not observed in the retinas of rats treated with TA. The change in expression of nNOS and iNOS were specific to parvalbumin and glial fibrillary acidic protein-positive cells. Treatment with TA prevented the increased expression of nNOS and iNOS in all samples. Conclusions: Hypoxia upregulates expression of nNOS and iNOS in OIR rat retinas, which is can be prevented by treatment with TA.
참고문헌 (35)
- Brafman A, "Inhibition of oxygen-induced retinopathy in RTP801-deficient mice", Invest Ophthalmol Vis Sci, 45, pp.3796~3805 (2004)
- Hammes HP, "Pericytes and the pathogenesis of diabetic retinopathy", Diabetes, 51, pp.3107~3112 (2002)
- Inatani M, "Expression of proteoglycan decorin in neural retina", Invest Ophthalmol Vis Sci, 40, pp.1783~1791 (1999)
- Ishida S, "VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization", J Exp Med, 198, pp.483~489 (2003)
- Downie LE, "Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity", J Comp Neurol, 504, pp.404~417 (2007)
- Kim YH, "Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia", Neurobiol Dis, 26, pp.569~576 (2007)
- Dawson VL, "Nitric oxide neurotoxicity", J Chem Neuroanat, 10, pp.179~190 (1996)
- Dawson VL, "Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures", Proc Natl Acad Sci U S A, 88, pp.6368~6371 (1991)
- Kaur C, "Cellular and vascular changes in the retina of neonatal rats after an acute exposure to hypoxia", Invest Ophthalmol Vis Sci, 50, pp.5364~5374 (2009)
- Kaur C, "Early response of neurons and glial cells to hypoxia in the retina", Invest Ophthalmol Vis Sci, 47, pp.1126~1141 (2006)
- Almeida A, "Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion", Brain Res, 790, pp.209~216 (1998)
- Osborne NN, "Retinal ischemia: mechanisms of damage and potential therapeutic strategies", Prog Retin Eye Res, 23, pp.91~147 (2004)
- Chemtob S, "Peroxide-cyclooxygenase interactions in postasphyxial changes in retinal and choroidal hemodynamics", J Appl Physiol, 78, pp.2039~2046 (1995)
- Hardy P, "Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy", Cardiovasc Res, 47, pp.489~509 (2000)
- Rey-Funes M, "Hypothermia prevents nitric oxide system changes in retina induced by severe perinatal asphyxia", J Neurosci Res, 89, pp.729~743 (2011)
- Lee EJ, "Neuronal nitric oxide synthase is expressed in the axotomized ganglion cells of the rat retina", Brain Res, 986, pp.174~180 (2003)
- Abraham IM, "Action of glucocorticoids on survival of nerve cells: promoting neurodegeneration or neuroprotection?", J Neuroendocrinol, 13, pp.749~760 (2001)
- Jonas JB, "Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases", Prog Retin Eye Res, 24, pp.587~611 (2005)
- Ozdek SC, "Effects of intravitreal triamcinolone injection on macular edema and visualprognosis in central retinal vein occlusion", Int Ophthalmol, 26, pp.27~34 (2005)
- Psarra AM, "Mitochondrial localization of glucocortocoid receptor in glial (Müller) cells in the salamander retina", Glia, 41, pp.38~49 (2003)
- Hartnett ME, "Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy", Invest Ophthalmol Vis Sci, 47, pp.4975~4982 (2006)
- Park YJ, "Treatment with triamcinolone acetonide prevents decreased retinal levels of decorin in a rat model of oxygen-induced retinopathy", Curr Eye Res, 35, pp.657~663 (2010)
- Park JW, "Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina", Neurobiol Dis, 21, pp.43~49 (2006)
- 박찬기, "Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma", VISION RESEARCH, 47, pp.2732~2740, PERGAMON-ELSEVIER SCIENCE LTD
- Leal EC, "Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy", Invest Ophthalmol Vis Sci, 48, pp.5257~5265 (2007)
- Woo Taek Kim, "Retinal Protective Effects of Resveratrol via Modulation of Nitric Oxide Synthase on Oxygen-induced Retinopathy", Korean Journal of Ophthalmology, 24(2), pp.108~118 (2010), 대한안과학회
- Jacobson LK, "Periventricular leukomalacia: an important cause of visual and ocular motility dysfunction in children", Surv Ophthalmol, 45, pp.1~13 (2000)
- Bredt DS, "Nitric oxide, a novel neuronal messenger", Neuron, 8, pp.3~11 (1992)
- Moncada S, "Nitric oxide: physiology, pathophysiology, and pharmacology", Pharmacol Rev, 43, pp.109~142 (1991)
- Raju TN, "Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials", J Pediatr, 131, pp.844~850 (1997)
- Rotschild T, "Dexamethasone reduces oxygen induced retinopathy in a mouse model", Pediatr Res, 46, pp.94~100 (1999)
- Wenzel A, "Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor", Invest Ophthalmol Vis Sci, 42, pp.1653~1659 (2001)
- Gwon JS, "The regulatory expression of neuronal nitric oxide synthase in the ischemic rat retina", Neuroreport, 12, pp.3385~3389 (2001)
- Bolanos JP, "Roles of nitric oxide in brain hypoxia-ischemia", Biochim Biophys Acta, 1411, pp.415~436 (1999)
- Oh SJ, "NOS-like immunoreactive neurons express GABA-like immunoreactivity in rabbit and rat retinae", Exp Brain Res, 120, pp.109~113 (1998)